Aloke Virmani Finn, MD
Associate Professor of Medicine, University of Maryland
Alternative Macrophages, Angiogenesis, and Plaque Progression in Atherosclerosis
Dr. Finn is an interventional cardiologist and internationally recognized expert in the field of vascular biology and vascular device research. He currently serves as medical director and chief of research of CVPath and is head of the institute’s basic and translational research laboratory. He is also an associate professor of medicine at the University of Maryland, where he serves (part-time) as a cardiologist and interventional cardiologist.
He has published more than 100 peer-reviewed research articles, editorials, and reviews. He is an editorial board member of Coronary Artery Disease and of Arteriosclerosis, Thrombosis, and Vascular Biology.
His research interests are in the area of vascular biology, particularly human vascular disease. He has focused in particular on 1) the molecular mechanisms by which mTOR inhibitors delay endothelial recovery and function after vascular injury; 2) the role of alternative macrophage phenotypes in human atherosclerosis; 3) preclinical research in drug delivery as it relates to both drug-eluting stents and balloons; and 4) pathologic responses to structural heart devices.
He obtained his medical degree from Vanderbilt University in 2000. During medical school, he received a Howard Hughes Medical Student Research Fellowship and studied vascular gene therapy under David Dichek at the University of California at San Francisco. Dr. Finn did his internal medicine, cardiology and interventional cardiology training at the Massachusetts General Hospital in Boston, including two years of vascular biology research with Drs. Herman Gold and Rakesh Jain. Dr. Finn came to CVPath from Emory University in Atlanta where, from 2007 through 2015, he was assistant professor of medicine and directed a basic and translational research laboratory.
Sarver Heart Center Grand Rounds - Guest Speaker Series
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dr. Finn has disclosed no conflicts.
All other faculty, CME Planning Committee members and CME office reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.
Describe recent progress in the research, diagnosis and treatment of heart disease
Integrate advances in heart disease diagnosis and treatment into the day-to-day practices of research and clinical care
Provide medical professionals with updates on cardiologic topics with the goals of increasing knowledge, competence and patient care.
Watch it live.